“small-cell-lung-cancer” Archives

in
Entry Author Date Location
Bio Roundup: A Royal IPO, Akili Arrives, Orca Bio Surfaces & More 06/19/20 National
At Big Lung Cancer Meeting, Lights Shine on KRAS, Drug Combos & More 09/09/19 National
$5.8B for Nothing: AbbVie Shelves Stemcentrx Drug After Latest Flop 08/29/19 Detroit Ann Arbor
Bio Roundup: Merger Drama, FDA Trauma, Big IPOs, CRISPR Fights & More 06/28/19 National
Bio Roundup: Array Bio Acquired, IPO Spree, Sanofi’s Job Cuts & More 06/21/19 National
Failed Clinical Trial Puts Eli Lilly Cancer Drug in Limbo 01/18/19 Indiana
Bristol Stumbles in Lung Cancer Again as Rivals Play Catch-Up 10/12/18 New York
Bio Roundup: EpiPen Shortage, Bluebird’s Bet, Biotech IPOs & More 08/24/18 National
Bio Roundup: Big Bucks For Calico, Data Dumps & The IPO Wave Rolls On 06/29/18 National
Eli Lilly Bolsters Cancer Drug Pipeline with $110M Deal for AurKa 05/14/18 Indiana
OncoMed Slashes Workforce After Two Clinical Trial Failures in Cancer 04/24/17 San Francisco
Xbiotech Responds to ESMO, Other Critics of Phase 3 Cancer Data 07/15/16 Texas
Immunogen Halts Study as Cancer Drug Flops, Shares Fall 11/05/13 Boston
Ziopharm Awaits Cancer Drug Data as Wall Street Withholds Judgment 08/29/12 New York
Page 1 of 1